News
Patient advocates called the OBBBA changes a “sweetheart deal to Big Pharma” and emphasized that these provisions forced ...
On Tuesday, patient advocacy groups rally to oppose changes to Medicaid and cash heading to pharmaceutical companies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback